Wan-Ting Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Wan-Ting Huang has a total of 484 co-authors. Here are the top co-authors by number of shared publications:
- Jen-Hsiang Chuang
Taiwan Centers for Disease Control, Taipei, Taiwan
16 shared publications Mei-Huei Chen
Institute of Population Health Sciences, Taiwan National Health Research Institutes, No. 35, Keyan Road, Zhunan Township, Miaoli County, 350, Taiwan; Department of Pediatrics, National Taiwan University College of Medicine and Hospital, No. 1, Section 1, Ren'ai Road, Zhongzheng District, Taipei City, 100, Taiwan
7 shared publications- TienYu Owen Yang
Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford , Oxford
5 shared publications - Wan-Chin Chen
Office of Preventive Medicine, Centers for Disease Control, Taipei, Taiwan
5 shared publications - Ding-Ping Liu
Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan
4 shared publications Kuan-Ying Arthur Huang
Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital and School of Medicine, Chang Gung University, Guishan District, Taoyuan City, 333, Taiwan
4 shared publications
Latest Publications
- 20 June 2026
- Published by Springer Nature in Drug Safety
- Vol. 49 (10) , 1223-1236
Developing a Hierarchical Algorithm to Identify Pregnancies and Determine Gestational Age from Nationwide Linked Health Data in Taiwan
Administrative health data are vital for investigating medication safety during pregnancy. In Taiwan, while the National Health Insurance Research Database (NHIRD) and Birth Certificate Application (BCA) capture pregnancy data, no standardized approach exists for integrating these sources to identify episodes and assign gestational age (GA). This study aimed to develop a hierarchical pregnancy-identification algorithm tailored to Taiwan's linked claims and birth registry data. We adapted an ICD-10-CM/PCS-based algorithm to the Taiwanese coding environment, incorporating clinician input, local billing practices, and birth registry information. The algorithm refines pregnancy outcome classification, estimates pregnancy start dates, and assigns GA. As a proof of concept, we applied the final algorithm to 2016-2022 data to summarize outcome distributions. We developed a seven-step hierarchical algorithm that uses claims codes to classify pregnancy outcomes, groups records into episodes using spacing rules, assigns pregnancy start dates from ordered prenatal services, validates and refines GA via linkage to the BCA database, determines the number of pregnancies and fetuses, and checks the plausibility of GA and inter-pregnancy intervals. A total of 1,696,229 pregnancies contributed by 1,169,779 women were identified; outcome distributions (69.3% live birth, 16.3% spontaneous abortion, 5.7% elective abortion, 6.0% ectopic pregnancy, 1.4% delivery with unknown outcome, 1.1% stillbirth, 0.2% trophoblastic and other abnormal products of conception) were consistent with national statistics and prior literature. This hierarchical algorithm provides a transparent, reproducible framework for identifying pregnancies and estimating GA in Taiwan. It establishes a critical foundation for future real-world studies of medication safety during pregnancy.
- 20 June 2026
- Published by Springer Nature in Drug Safety
- Vol. 49 (10) , 1223-1236
Developing a Hierarchical Algorithm to Identify Pregnancies and Determine Gestational Age from Nationwide Linked Health Data in Taiwan
Administrative health data are vital for investigating medication safety during pregnancy. In Taiwan, while the National Health Insurance Research Database (NHIRD) and Birth Certificate Application (BCA) capture pregnancy data, no standardized approach exists for integrating these sources to identify episodes and assign gestational age (GA). This study aimed to develop a hierarchical pregnancy-identification algorithm tailored to Taiwan's linked claims and birth registry data. We adapted an ICD-10-CM/PCS-based algorithm to the Taiwanese coding environment, incorporating clinician input, local billing practices, and birth registry information. The algorithm refines pregnancy outcome classification, estimates pregnancy start dates, and assigns GA. As a proof of concept, we applied the final algorithm to 2016-2022 data to summarize outcome distributions. We developed a seven-step hierarchical algorithm that uses claims codes to classify pregnancy outcomes, groups records into episodes using spacing rules, assigns pregnancy start dates from ordered prenatal services, validates and refines GA via linkage to the BCA database, determines the number of pregnancies and fetuses, and checks the plausibility of GA and inter-pregnancy intervals. A total of 1,696,229 pregnancies contributed by 1,169,779 women were identified; outcome distributions (69.3% live birth, 16.3% spontaneous abortion, 5.7% elective abortion, 6.0% ectopic pregnancy, 1.4% delivery with unknown outcome, 1.1% stillbirth, 0.2% trophoblastic and other abnormal products of conception) were consistent with national statistics and prior literature. This hierarchical algorithm provides a transparent, reproducible framework for identifying pregnancies and estimating GA in Taiwan. It establishes a critical foundation for future real-world studies of medication safety during pregnancy.
- Open Access
- 5 November 2025
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 113 (5) , 945-949
Strengthening New Vaccine Introduction in Low- and Middle-Income Countries: Establishing Hospital-Based Sentinel Surveillance for Vaccine Safety Monitoring
: Enhancing surveillance for adverse events following immunization remains a key global immunization priority. Many low- and middle-income countries (LMICs) are implementing new vaccines without the comprehensive safety monitoring typically conducted in high-income countries. Since 2017, the Global Immunization Safety Team at the US Centers for Disease Control and Prevention, in collaboration with partners, has supported establishing sentinel surveillance systems during vaccine introductions for safety monitoring in LMICs. Through these experiences, many lessons have been learned regarding project initiation, funding opportunities, standardizing data collection, background rate challenges, site selection considerations, and partner coordination. If vaccine safety is prioritized, sentinel surveillance enhances routine monitoring and generates valuable safety data, strengthening the immunization and regulatory programs. As many countries introduce and manufacture vaccines not previously monitored in high-income countries, lessons from safety monitoring during earlier vaccine introductions must be applied. Sustaining the gains in immunization that were hard-earned over the past decades depends on it.
- 5 November 2025
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 113 (5) , 945-949
Open AccessStrengthening New Vaccine Introduction in Low- and Middle-Income Countries: Establishing Hospital-Based Sentinel Surveillance for Vaccine Safety Monitoring
: Enhancing surveillance for adverse events following immunization remains a key global immunization priority. Many low- and middle-income countries (LMICs) are implementing new vaccines without the comprehensive safety monitoring typically conducted in high-income countries. Since 2017, the Global Immunization Safety Team at the US Centers for Disease Control and Prevention, in collaboration with partners, has supported establishing sentinel surveillance systems during vaccine introductions for safety monitoring in LMICs. Through these experiences, many lessons have been learned regarding project initiation, funding opportunities, standardizing data collection, background rate challenges, site selection considerations, and partner coordination. If vaccine safety is prioritized, sentinel surveillance enhances routine monitoring and generates valuable safety data, strengthening the immunization and regulatory programs. As many countries introduce and manufacture vaccines not previously monitored in high-income countries, lessons from safety monitoring during earlier vaccine introductions must be applied. Sustaining the gains in immunization that were hard-earned over the past decades depends on it.
- Open Access
- 10 April 2025
- Published by Elsevier in eClinicalMedicine
- Vol. 82, 103171
Interaction between influenza vaccine and statins affecting the risk of rhabdomyolysis in Taiwan: a nationwide case-centred analysis
- 10 April 2025
- Published by Elsevier in eClinicalMedicine
- Vol. 82, 103171
Open AccessInteraction between influenza vaccine and statins affecting the risk of rhabdomyolysis in Taiwan: a nationwide case-centred analysis
- Open Access
- 5 March 2024
- Published by Springer Nature in Drug Safety
- Vol. 47 (4) , 401-402
Comment on “Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance”
- 5 March 2024
- Published by Springer Nature in Drug Safety
- Vol. 47 (4) , 401-402
Open AccessComment on “Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance”
- 14 December 2022
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 107 (6) , 1351-1354
Assessing the Brighton Collaboration Case Definition of Sensorineural Hearing Loss in Ghana
The Brighton Collaboration has developed a case definition to assess sensorineural hearing loss (SNHL) as an adverse event of special interest for Lassa fever vaccines. We applied the level of diagnostic certainty (LOC) criteria to 300 SNHL patients aged 18 to 59 years at a tertiary hospital in Ghana from January 2017 through June 2020 and evaluated the applicability of this definition. Most SNHL cases were assessable (85.0%) and assigned level 1 LOC (84.3%); missing information on otoscopy (86.7%) was the main reason for being unable to classify cases. Consistency of LOC classification between assessors was 99.3%. Cases with electronic medical records (EMRs) were less assessable than those with paper records (30.9% versus 93.8%). These findings indicate that the SNHL definition would be applicable to retrospectively ascertain and classify cases in resource-limited settings. Developing an EMR template to document otoscopy results may improve the feasibility at this hospital to ascertain SNHL.
- 14 December 2022
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 107 (6) , 1351-1354
Assessing the Brighton Collaboration Case Definition of Sensorineural Hearing Loss in Ghana
The Brighton Collaboration has developed a case definition to assess sensorineural hearing loss (SNHL) as an adverse event of special interest for Lassa fever vaccines. We applied the level of diagnostic certainty (LOC) criteria to 300 SNHL patients aged 18 to 59 years at a tertiary hospital in Ghana from January 2017 through June 2020 and evaluated the applicability of this definition. Most SNHL cases were assessable (85.0%) and assigned level 1 LOC (84.3%); missing information on otoscopy (86.7%) was the main reason for being unable to classify cases. Consistency of LOC classification between assessors was 99.3%. Cases with electronic medical records (EMRs) were less assessable than those with paper records (30.9% versus 93.8%). These findings indicate that the SNHL definition would be applicable to retrospectively ascertain and classify cases in resource-limited settings. Developing an EMR template to document otoscopy results may improve the feasibility at this hospital to ascertain SNHL.
- Open Access
- 26 February 2021
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 30 (7) , 843-857
Suitability of databases in the Asia‐Pacific for collaborative monitoring of vaccine safety
Introduction: Information regarding availability of electronic healthcare databases in the Asia‐Pacific region is critical for planning vaccine safety assessments particularly, as COVID‐19 vaccines are introduced. This study aimed to identify data sources in the region, potentially suitable for vaccine safety surveillance. This manuscript is endorsed by the International Society for Pharmacoepidemiology (ISPE).Methods: Nineteen countries targeted for database reporting were identified using published country lists and review articles. Surveillance capacity was assessed using two surveys: a 9‐item introductory survey and a 51‐item full survey. Survey questions related to database characteristics, covariate and health outcome variables, vaccine exposure characteristics, access and governance, and dataset linkage capability. Other questions collated research/regulatory applications of the data and local publications detailing database use for research.Results: Eleven databases containing vaccine‐specific information were identified across 8 countries. Databases were largely national in coverage (8/11, 73%), encompassed all ages (9/11, 82%) with population size from 1.4 to 52 million persons. Vaccine exposure information varied particularly for standardized vaccine codes (5/11, 46%), brand (7/11, 64%) and manufacturer (5/11, 46%). Outcome data were integrated with vaccine data in 6 (55%) databases and available via linkage in 5 (46%) databases. Data approval processes varied, impacting on timeliness of data access.Conclusions: Variation in vaccine data availability, complexities in data access including, governance and data release approval procedures, together with requirement for data linkage for outcome information, all contribute to the challenges in building a distributed network for vaccine safety assessment in the Asia‐Pacific and globally. Common data models (CDMs) may help expedite vaccine safety research across the region.
- 26 February 2021
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 30 (7) , 843-857
Open AccessSuitability of databases in the Asia‐Pacific for collaborative monitoring of vaccine safety
Introduction: Information regarding availability of electronic healthcare databases in the Asia‐Pacific region is critical for planning vaccine safety assessments particularly, as COVID‐19 vaccines are introduced. This study aimed to identify data sources in the region, potentially suitable for vaccine safety surveillance. This manuscript is endorsed by the International Society for Pharmacoepidemiology (ISPE).Methods: Nineteen countries targeted for database reporting were identified using published country lists and review articles. Surveillance capacity was assessed using two surveys: a 9‐item introductory survey and a 51‐item full survey. Survey questions related to database characteristics, covariate and health outcome variables, vaccine exposure characteristics, access and governance, and dataset linkage capability. Other questions collated research/regulatory applications of the data and local publications detailing database use for research.Results: Eleven databases containing vaccine‐specific information were identified across 8 countries. Databases were largely national in coverage (8/11, 73%), encompassed all ages (9/11, 82%) with population size from 1.4 to 52 million persons. Vaccine exposure information varied particularly for standardized vaccine codes (5/11, 46%), brand (7/11, 64%) and manufacturer (5/11, 46%). Outcome data were integrated with vaccine data in 6 (55%) databases and available via linkage in 5 (46%) databases. Data approval processes varied, impacting on timeliness of data access.Conclusions: Variation in vaccine data availability, complexities in data access including, governance and data release approval procedures, together with requirement for data linkage for outcome information, all contribute to the challenges in building a distributed network for vaccine safety assessment in the Asia‐Pacific and globally. Common data models (CDMs) may help expedite vaccine safety research across the region.